Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00241904 · ClinicalTrials.gov registry record · Phase 4
Reducing Total Cardiovascular Risk in an Urban Community
A Phase 4 study, sponsored by Johns Hopkins University.
- Completed
- Registry status
- Phase 4
- Development phase
- 525
- Enrollment target
NCT00241904: Completed Phase 4 study, sponsored by Johns Hopkins University.
NCT00241904 is a Phase 4 study that has completed, run by Johns Hopkins University. The registered enrollment target is 525 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00241904, a Phase 4 study, has completed, sponsored by Johns Hopkins University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 525 participants
- Enrollment target
Study Summary
PLEASE NOTE: THIS STUDY IS ONLY ENROLLING PATIENTS CURRENTLY BEING TREATED AT BELAIR-EDISON FAMILY HEALTH CENTER. The purpose of this study is to compare the clinical effectiveness and cost effectiveness of two cardiovascular risk reduction programs - a comprehensive intensive (Cl) intervention with a less intensive (LI) intervention - in African American, and white low-income patients with known excessive cardiovascular disease risk.
Interventions
- DRUG Beta Blocker
- DRUG ACE Inhibitors
- BEHAVIORAL Lifestyle Changes
- DRUG Antiplatelet Agents
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 525 participants |
| Start Date | 2006-05 |
| Est. Completion | 2010-05 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00241904
The ClinicalTrials.gov registry entry for NCT00241904 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 525 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Beta Blocker is the first listed.
NCT00241904 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00241904 about?
NCT00241904 is a clinical study titled "Reducing Total Cardiovascular Risk in an Urban Community". PLEASE NOTE: THIS STUDY IS ONLY ENROLLING PATIENTS CURRENTLY BEING TREATED AT BELAIR-EDISON FAMILY HEALTH CENTER. The purpose of this study is to compare the clinical effectiveness and cost effectiveness of two cardiovascular risk reduction programs - a comprehensive intensive (Cl) intervention wit...
What is the current status of trial NCT00241904?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 525 participants. The study started on 2006-05. Estimated completion is 2010-05.
What interventions are being tested in trial NCT00241904?
The interventions under investigation include: Beta Blocker (DRUG), ACE Inhibitors (DRUG), Lifestyle Changes (BEHAVIORAL), Antiplatelet Agents (DRUG).
Who is sponsoring clinical trial NCT00241904?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.